Evommune, Inc. ( EVMN) - Key Metrics
EVMN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.89 | -$0.56 | -$0.57 |
| 2026Q1 | $0 | -$0.64 | -$0.82 | -$0.82 |
| 2025Q4 | $0 | -$0.90 | -$0.53 | -$0.53 |
| 2025Q3 | $0.32 | -$0.40 | -$0.31 | -$0.31 |
| 2025Q2 | $0 | -$0.45 | -$0.87 | -$0.87 |
EVMN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.73 |
| 2026Q1 | 0% | -8.98 |
| 2025Q4 | 0% | -4.76 |
| 2025Q3 | 0% | -12.64 |
| 2025Q2 | 0% | -11.24 |
EVMN
Price: $14.65
52 week price:
Earnings Per Share: -11.75 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 512.4 million